×
ADVERTISEMENT

OCTOBER 15, 2021

Recommends Approval

FDA Advisory Committee Votes on Moderna COVID-19 Vaccine Booster

By Marie Rosenthal

In a unanimous vote, 19 members of the FDA Vaccines and Related Biological Products Advisory Committee recommended boosters for the Moderna COVID-19 vaccine.

The recommendation will affect a large group of people in the United States. VRBPAC voted to recommend an expansion of Moderna’s emergency use authorization (EUA) for its messenger RNA (mRNA) vaccine for those who are:

  • 65 years and older;
  • 18 to 64 years of age with a high risk for severe COVID-19; and
  • 18 to 64 years of